ConvaTec Group (LON:CTEC) Stock Price Passes Below 50-Day Moving Average – Should You Sell?

Shares of ConvaTec Group PLC (LON:CTECGet Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 228.45 ($2.96) and traded as low as GBX 211.80 ($2.75). ConvaTec Group shares last traded at GBX 213.40 ($2.77), with a volume of 6,968,435 shares.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Royal Bank of Canada decreased their price target on ConvaTec Group from GBX 320 ($4.15) to GBX 305 ($3.96) and set an “outperform” rating for the company in a research note on Wednesday, July 31st. Berenberg Bank reaffirmed a “buy” rating and set a GBX 310 ($4.02) target price on shares of ConvaTec Group in a research report on Tuesday, August 6th. Finally, JPMorgan Chase & Co. decreased their target price on ConvaTec Group from GBX 323 ($4.19) to GBX 290 ($3.76) and set an “overweight” rating for the company in a research report on Wednesday, July 31st.

View Our Latest Report on ConvaTec Group

ConvaTec Group Trading Up 0.9 %

The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. The stock has a 50-day simple moving average of GBX 227.62 and a two-hundred day simple moving average of GBX 241.24. The firm has a market capitalization of £4.42 billion, a P/E ratio of 3,590.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64.

ConvaTec Group Company Profile

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Further Reading

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.